NASDAQ:ACRX

AcelRx Pharmaceuticals Earning Date

USA |NASDAQ |USD

ACRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.07 $-0.08 $-0.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $1.90M $443.00K $1.37M

Acelrx Pharmaceuticals's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ACRX Earnings Date & History Chart

ACRX Earnings & Revenue Forecast

ACRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.07 $-0.08 $-0.06
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.30 $-0.31 $-0.30
Dec 2022 2 $0.08 $-0.06 $0.22

ACRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.07 $-0.05 $-0.05
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.30 $-0.27 $-0.27
Dec 2022 0 / 0 $0.08 $0.09 $0.09

ACRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $2.22M $1.70M $2.75M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $5.10M $4.90M $5.30M
Dec 2022 2 $66.80M $46.70M $86.91M

ACRX Earnings Date & Revenue History

ACRX Earnings History

|
Show More
Show More

ACRX Revenue History

|
Show More
Show More

Acelrx Pharmaceuticals Next Earnings Date & Report

ACRX Next Earnings Date & Report Preview: Sep 2021 (FQ)

ACRX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Acelrx Pharmaceuticals's next quarterly earnings is $-0.07, with a low EPS estimation of $-0.08, and a high estimation of $-0.06.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.07, the last 2 month trend is $-0.06, and the 3 month trend is $-0.06.

Based on 2 analysts, the average revenue estimation is $1.90M, with a low revenue estimation of $1.20M, and a high estimation of $2.60M.

Acelrx Pharmaceuticals Previous Earnings Dates & Reports

ACRX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Acelrx Pharmaceuticals's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

ACRX's earnings per share (EPS) was $-0.08.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and higher than the same period a year before (Jun 2020) by 0.00%.

Revenues were $443.00K, better than the forecast of $443.00K by 0.00%, down by -13.31% from the previous quarter , and down by -84.85% from the same period last year.

The company reported a net income of $-9.85M.

Free cash flow for the quarter was $-9.94M , compared to $-9.73M last quarter and $-9.79M a year before.

ACRX ended the quarter with $22.76M in total debt, an increase of 11.72% compared to the previous quarter, and a decrease of -16.05% compared to the same quarter a year before.

ACRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Acelrx Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

ACRX's earnings per share (EPS) was $-0.48, beating the consensus analysts forecast of $-0.48 by 0.00% , and higher than the previous year's EPS (Dec 2019) by -28.36%.

Revenues were $5.42M, worse than the forecast of $6.38M by -15.11%, and up by 136.61% from previous year's revenue.

The company reported a net income of $-40.38M.

Acelrx Pharmaceuticals reported a free cash flow of $-40.36M for its fiscal year, compared to $-54.65M a year ago.

The company ended the fiscal year with $22.99M in total debt, a decrease of -11.96% compared to the previous year.